FDA Issues Emergency Use Authorization for COVID-19 Drug, Revokes Eli Lilly's Authorization

Summary

The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for a COVID-19 drug, following a public health emergency declaration by the Secretary of Health and Human Services in February 2020, and revoked Eli Lilly's authorization for bamlanivimab, a drug previously authorized for emergency use during the pandemic.